Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.

Kang HY, Kim KH, Kim JH, Kim HM, Kim J, Kim MS, El Khoury AC, Kim DS.

Asia Pac J Public Health. 2013 Mar;25(2):145-58. doi: 10.1177/1010539511416806. Epub 2012 Jan 10.

PMID:
22234827
2.

Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.

Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P.

Vaccine. 2012 Apr 16;30(18):2839-47. doi: 10.1016/j.vaccine.2012.02.047. Epub 2012 Mar 2.

PMID:
22387220
3.

[A cost-effectiveness analysis on universal infant rotavirus vaccination strategy in China].

Sun SL, Gao YQ, Yin J, Zhuang GH.

Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Feb;37(2):238-42. doi: 10.3760/cma.j.issn.0254-6450.2016.02.018. Chinese.

PMID:
26917523
4.

Cost-effectiveness of childhood rotavirus vaccination in Taiwan.

Wu CL, Yang YC, Huang LM, Chen KT.

Vaccine. 2009 Mar 4;27(10):1492-9. doi: 10.1016/j.vaccine.2009.01.023. Epub 2009 Jan 30.

PMID:
19186200
5.

Cost-effectiveness of a new rotavirus vaccination program in Pakistan: a decision tree model.

Patel HD, Roberts ET, Constenla DO.

Vaccine. 2013 Dec 9;31(51):6072-8. doi: 10.1016/j.vaccine.2013.10.022. Epub 2013 Oct 29.

6.

Potential epidemiological and economical impact of two rotavirus vaccines in Colombia.

De la Hoz F, Alvis N, Narváez J, Cediel N, Gamboa O, Velandia M.

Vaccine. 2010 May 14;28(22):3856-64. doi: 10.1016/j.vaccine.2010.03.004. Epub 2010 Mar 26.

PMID:
20347057
7.

Cost-effectiveness analysis of a rotavirus immunization program for the United States.

Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI.

JAMA. 1998 May 6;279(17):1371-6.

PMID:
9582045
8.

Cost-effectiveness of a pentavalent human-bovine reassortant rotavirus vaccine for children ≤5 years of age in Taiwan.

Itzler RF, Chen PY, Lac C, El Khoury AC, Cook JR.

J Med Econ. 2011;14(6):748-58. doi: 10.3111/13696998.2011.614303. Epub 2011 Sep 15.

PMID:
21919673
9.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
10.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
11.

Cost effectiveness evaluation of a rotavirus vaccination program in Argentina.

Martí SG, Alcaraz A, Valanzasca P, McMullen M, Standaert B, Garay U, Lepetic A, Gomez J.

Vaccine. 2015 Oct 13;33(42):5684-5690. doi: 10.1016/j.vaccine.2015.08.026. Epub 2015 Aug 21.

PMID:
26303875
12.

Cost-effectiveness analysis of rotavirus vaccination in Argentina.

Urueña A, Pippo T, Betelu MS, Virgilio F, Hernández L, Giglio N, Gentile Á, Diosque M, Vizzotti C.

Vaccine. 2015 May 7;33 Suppl 1:A126-34. doi: 10.1016/j.vaccine.2014.12.074.

PMID:
25919152
13.

Economic evaluation of a routine rotavirus vaccination programme in Indonesia.

Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A.

Vaccine. 2009 Nov 20;27 Suppl 5:F67-74. doi: 10.1016/j.vaccine.2009.09.040.

PMID:
19931723
14.

Cost-effectiveness analysis of the introduction of rotavirus vaccine in Iran.

Javanbakht M, Moradi-Lakeh M, Yaghoubi M, Esteghamati A, Mansour Ghanaie R, Mahmoudi S, Shamshiri AR, Zahraei SM, Baxter L, Shakerian S, Chaudhri I, Fleming JA, Munier A, Baradaran HR.

Vaccine. 2015 May 7;33 Suppl 1:A192-200. doi: 10.1016/j.vaccine.2014.12.035.

PMID:
25919160
15.
16.

Cost-effectiveness of Rotavirus vaccination in Vietnam.

Kim SY, Goldie SJ, Salomon JA.

BMC Public Health. 2009 Jan 21;9:29. doi: 10.1186/1471-2458-9-29.

17.

Cost-effectiveness of childhood rotavirus vaccination in Germany.

Aidelsburger P, Grabein K, Böhm K, Dietl M, Wasem J, Koch J, Ultsch B, Weidemann F, Wichmann O.

Vaccine. 2014 Apr 7;32(17):1964-74. doi: 10.1016/j.vaccine.2014.01.061. Epub 2014 Feb 20.

PMID:
24561052
18.

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

Standaert B, Parez N, Tehard B, Colin X, Detournay B.

Appl Health Econ Health Policy. 2008;6(4):199-216. doi: 10.2165/00148365-200806040-00003.

PMID:
19382820
19.

Cost-Effectiveness of Monovalent Rotavirus Vaccination of Infants in Malawi: A Postintroduction Analysis Using Individual Patient-Level Costing Data.

Bar-Zeev N, Tate JE, Pecenka C, Chikafa J, Mvula H, Wachepa R, Mwansambo C, Mhango T, Chirwa G, Crampin AC, Parashar UD, Costello A, Heyderman RS, French N, Atherly D, Cunliffe NA; VACSURV Consortium.

Clin Infect Dis. 2016 May 1;62 Suppl 2:S220-8. doi: 10.1093/cid/civ1025.

20.

Cost-effectiveness of rotavirus immunization in Indonesia: taking breastfeeding patterns into account.

Suwantika AA, Tu HA, Postma MJ.

Vaccine. 2013 Jul 11;31(32):3300-7. doi: 10.1016/j.vaccine.2013.04.055. Epub 2013 May 21.

PMID:
23707163

Supplemental Content

Support Center